PATEL DINESH V PH D — SEC insider filings
SEC reporting owner CIK 1120477. 44 insider filings on record with FilingPulse; latest filed 2026-11-20.
Transaction summary — filings shown
Covers all 44 filings on record, filed 2021-01-20 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 27 legs across 17 filings — 885,475 shares, $74,401,465 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 78.
- Largest priced transaction: sale of 65,761 shares @ $149.11 ($9,805,623) in Protagonist Therapeutics, Inc, filed 2026-08-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | President and CEO, Director | 44 | — | 27 legs · 885,475 sh · $74,401,465 | 78 |
Insider filings — PATEL DINESH V PH D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-20 | 4 | Protagonist Therapeutics, Inc (PTGX) | Gift (G): 300 @ $0 | EDGAR |
| 2026-09-10 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 54,174 @ $21.58 · Sale (S): 54,174 @ $145.87 · Option exercise (M): 63,548 @ $21.58 · Sale (S): 63,548 @ $146.18 · Option exercise (M): 7,278 @ $21.58 · Sale (S): 7,278 @ $144.10 · +3 more | EDGAR |
| 2026-09-08 | 4 | Protagonist Therapeutics, Inc (PTGX) | Gift (G): 510 @ $0 | EDGAR |
| 2026-08-12 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 65,761 @ $21.58 · Sale (S): 65,761 @ $149.11 · Option exercise (M): 34,239 @ $21.58 · Sale (S): 34,239 @ $148.52 · Option exercise (M): 65,761 (derivative) @ $0 · Option exercise (M): 34,239 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4/A | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 75,000 @ $21.58 · Sale (S): 75,000 @ $100.12 · Option exercise (M): 75,000 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 75,000 @ $21.58 · Sale (S): 75,000 @ $100.12 · Option exercise (M): 75,000 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | Protagonist Therapeutics, Inc (PTGX) | Gift (G): 1,460 @ $0 | EDGAR |
| 2026-03-25 | 4 | Protagonist Therapeutics, Inc (PTGX) | Gift (G): 50,000 @ $0 · Option exercise (M): 59 @ $8.58 · Sale (S): 59 @ $101 · Option exercise (M): 54,641 @ $8.58 · Sale (S): 54,641 @ $101 · Option exercise (M): 59 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-27 | 4 | Protagonist Therapeutics, Inc (PTGX) | Gift (G): 6,000 @ $0 · Option exercise (M): 19,315 @ $4.21 · Sale (S): 19,315 @ $84.59 · Option exercise (M): 10,685 @ $4.21 · Sale (S): 10,685 @ $84 · Option exercise (M): 14,205 @ $21.58 · +7 more | EDGAR |
| 2026-01-21 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 34,438 @ $82.48 | EDGAR |
| 2026-01-06 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 95,400 @ $0 · Grant/award (A): 120,200 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Protagonist Therapeutics, Inc (PTGX) | Gift (G): 440 @ $0 | EDGAR |
| 2025-09-18 | 4 | Protagonist Therapeutics, Inc (PTGX) | Gift (G): 620 @ $0 | EDGAR |
| 2025-07-28 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 10,415 @ $54.78 | EDGAR |
| 2025-07-23 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 25,000 @ $0 · Sale (S): 12,859 @ $54.86 · Sale (S): 22,065 @ $55.05 · Sale (S): 17,520 @ $54.79 | EDGAR |
| 2025-07-18 | 4 | Protagonist Therapeutics, Inc (PTGX) | Gift (G): 5,000 @ $0 | EDGAR |
| 2025-06-17 | 4 | Protagonist Therapeutics, Inc (PTGX) | Gift (G): 670 @ $0 · Gift (G): 685 @ $0 | EDGAR |
| 2025-03-05 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 24,000 @ $4.21 · Option exercise (M): 24,000 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 5,359 @ $38.18 | EDGAR |
| 2025-01-17 | 4 | Protagonist Therapeutics, Inc (PTGX) | Tax withholding (F): 12,636 @ $0 | EDGAR |
| 2025-01-06 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 149,800 @ $0 · Grant/award (A): 181,472 (derivative) @ $0 | EDGAR |
| 2024-11-27 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 78,520 @ $46.96 · Gift (G): 7,000 @ $0 · Option exercise (M): 1,727 @ $21.58 · Sale (S): 21,480 @ $46.25 · Option exercise (M): 1,727 (derivative) @ $0 | EDGAR |
| 2024-11-21 | 4 | Protagonist Therapeutics, Inc (PTGX) | Gift (G): 1,000 @ $0 | EDGAR |
| 2024-06-17 | 4 | Protagonist Therapeutics, Inc (PTGX) | Gift (G): 1,000 @ $0 | EDGAR |
| 2024-06-11 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 35,000 @ $35.19 | EDGAR |
| 2024-04-02 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 25,000 @ $28.31 | EDGAR |
| 2024-03-01 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 30,000 @ $31.62 | EDGAR |
| 2024-02-28 | 4 | Protagonist Therapeutics, Inc (PTGX) | Tax withholding (F): 10,915 @ $29.53 | EDGAR |
| 2024-02-20 | 4 | Protagonist Therapeutics, Inc (PTGX) | Tax withholding (F): 3,717 @ $28.23 | EDGAR |
| 2024-01-04 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 84,875 @ $0 · Grant/award (A): 315,250 (derivative) @ $0 | EDGAR |
| 2023-12-15 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 75,000 @ $20.08 | EDGAR |
| 2023-10-19 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 6,000 @ $4.21 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | Protagonist Therapeutics, Inc (PTGX) | Gift (G): 10,000 @ $0 · Grant/award (A): 30,000 @ $0 · Tax withholding (F): 12,165 @ $26.07 | EDGAR |
| 2023-01-18 | 4 | Protagonist Therapeutics, Inc (PTGX) | Gift (G): 3,000 @ $0 · Gift (G): 3,116 @ $0 · Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2022-08-24 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 20,000 @ $4.21 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2022-05-04 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 15,742 @ $4.21 · Option exercise (M): 15,742 (derivative) @ $0 | EDGAR |
| 2022-04-26 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 30,000 @ $4.21 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2022-04-14 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 34,087 @ $1.89 · Option exercise (M): 34,087 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Protagonist Therapeutics, Inc (PTGX) | Tax withholding (F): 4,648 @ $24.28 | EDGAR |
| 2022-02-17 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 31,250 @ $0 · Grant/award (A): 187,500 (derivative) @ $0 | EDGAR |
| 2021-12-23 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 15,000 @ $32.14 | EDGAR |
| 2021-09-21 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 40,000 @ $4.21 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2021-02-26 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 25,000 @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2021-01-20 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 13,000 @ $4.21 · Sale (S): 24,846 @ $24.60 · Option exercise (M): 13,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1120477 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs